Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Development of a FibroScan Liver Examination Using a Single Probe

This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).

Participants needed: 309
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: EchosensUpdated: Feb 10, 2026Locations: 4
Eligibility criteria

Adult patients (≥ 18 years of age). [+3]

Vulnerable patients. [+4]

Status: Not yet recruiting

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.

Participants needed: 149
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: EchosensUpdated: Oct 30, 2025Locations: 7
Eligibility criteria

Have read, understood, and signed the informed consent form (ICF) [+2]

Inability to consent [+7]

Status: Recruiting

Development of a New Method for Liver Stiffness Measurement Using FibroScan

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Participants needed: 114
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: EchosensUpdated: Aug 14, 2025Locations: 2
Eligibility criteria

Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology d... [+2]

Vulnerable patients [+2]